By Special Press Release
- Largest single year investment in research since the organization’s founding
- In Maryland, $759,733 has been awarded to advance research efforts
Towson, MD, NOV. 8, 2023 — The Alzheimer’s Association today announces a landmark $100 million investment into research initiatives in 2023. This unparalleled commitment stands as the largest single-year investment since the organization’s founding in 1980.
In 2023, the Alzheimer’s Association funded 271 scientific investigations from researchers at all career levels examining topics across the spectrum of dementia science. The Association’s global, cumulative impact on research now includes more than $360 million invested in over 1,000 active research projects in 53 countries, spanning six continents.
Here in Maryland, $759,733 has been awarded to advance research efforts. This includes research being conducted at Johns Hopkins School of Public Health investigating the needs of persons living with dementia and hearing loss and how to develop new strategies to improve hearing care for these individuals.
“The only way we will achieve a world without Alzheimer’s is through research. This critical funding at the Johns Hopkins and with other researchers gets us closer to breakthroughs in diagnosis, treatment and prevention, and is part of a broader Alzheimer’s Association effort to eliminate Alzheimer’s and all other dementia,” said David McShea, executive director, Greater Maryland Chapter.
In addition to research grant funding, the Association’s investment in research supports a wide range of global leadership initiatives:
● Global scientific/medical conferences, including the field’s largest and most prestigious event: the annual Alzheimer’s Association International Conference® (AAIC). Nearly 11,000 scientists attended AAIC 2023 from 110 countries.
● Three influential peer-reviewed journals, including the flagship Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
● TrialMatch® — a free clinical studies matching service.
● The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) — an inclusive global network of more than 10,000 members representing over 120 countries.
Alzheimer’s is the sixth-leading cause of death in the United States. It kills more Americans than diabetes, and more than breast cancer and prostate cancer combined. More than 6 million Americans are living with Alzheimer’s disease, according to the Alzheimer’s Association 2023 Alzheimer’s Disease Facts and Figures. By 2050, the number of people with Alzheimer’s is projected to increase to nearly 13 million, barring the development of medical breakthroughs to prevent, slow or stop the disease. Maryland is the state with the nation’s highest dementia prevalence for residents age 65 and older and Baltimore City is the nation’s second highest region with 16.6%.
For more information, visit the Alzheimer’s Association at alz.org.
About the Alzheimer’s Association
The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer’s and all other dementia®. Visit alz.org or call 800.272.3900.
The post ALZHEIMER’S ASSOCIATION ANNOUNCES MILESTONE OF$100 MILLION INVESTED IN RESEARCH IN 2023 appeared first on AFRO American Newspapers .
